Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$306.88 - $380.0 $423,187 - $524,020
1,379 New
1,379 $521,000
Q2 2023

Aug 03, 2023

SELL
$346.15 - $392.09 $904,143 - $1.02 Million
-2,612 Reduced 37.28%
4,394 $1.68 Million
Q1 2023

May 04, 2023

BUY
$323.56 - $373.36 $2.27 Million - $2.62 Million
7,006 New
7,006 $2.62 Million
Q2 2021

Aug 05, 2021

BUY
$372.36 - $412.07 $841,533 - $931,278
2,260 New
2,260 $896,000
Q3 2020

Nov 02, 2020

SELL
$280.08 - $347.78 $316,490 - $392,991
-1,130 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$243.44 - $359.98 $796,779 - $1.18 Million
-3,273 Reduced 74.34%
1,130 $312,000
Q4 2019

Feb 07, 2020

SELL
$281.18 - $322.05 $1.51 Million - $1.73 Million
-5,387 Reduced 55.03%
4,403 $1.42 Million
Q3 2019

Nov 07, 2019

SELL
$294.25 - $341.49 $6.11 Million - $7.09 Million
-20,767 Reduced 67.96%
9,790 $2.91 Million
Q2 2019

Jul 29, 2019

BUY
$279.29 - $336.89 $2.64 Million - $3.19 Million
9,470 Added 44.91%
30,557 $10.3 Million
Q1 2019

Apr 25, 2019

SELL
$246.18 - $297.25 $7.2 Million - $8.69 Million
-29,241 Reduced 58.1%
21,087 $6.25 Million
Q4 2018

Feb 11, 2019

SELL
$232.7 - $281.66 $35.1 Million - $42.5 Million
-150,828 Reduced 74.98%
50,328 $12.8 Million
Q3 2018

Nov 05, 2018

SELL
$236.3 - $277.15 $17 Million - $20 Million
-72,014 Reduced 26.36%
201,156 $55.8 Million
Q2 2018

Jul 31, 2018

SELL
$217.98 - $237.23 $804,782 - $875,853
-3,692 Reduced 1.33%
273,170 $64.3 Million
Q1 2018

Apr 27, 2018

BUY
$218.74 - $251.43 $837,992 - $963,228
3,831 Added 1.4%
276,862 $63.3 Million
Q4 2017

Feb 05, 2018

BUY
$217.88 - $244.43 $5 Million - $5.61 Million
22,949 Added 9.18%
273,031 $59.5 Million
Q3 2017

Nov 06, 2017

SELL
$231.6 - $253.39 $10.8 Million - $11.8 Million
-46,678 Reduced 15.73%
250,082 $59.3 Million
Q2 2017

Aug 09, 2017

BUY
N/A
296,760
296,760 $71.1 Million

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.